(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INFUDYNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INFUDYNE

ST13

US500000088007812

Class

35, 41, 44

Filing

88007812

Registration

6075556

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

05/31/2026

Trademark type

Word

Nice classes

35, 41, 44

Filing date

06/20/2018

Registration date

06/09/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/09/2020

Last transaction

05/31/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/14/2019

First use in commerce

02/14/2019

Drawing code

4

Owner type

03

Owner location

Southfield, MI, US

Examiner

ANKRAH, NAAKWAMA S

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LUCENT Surgical Support Systems, Inc.
LUCENT Surgical Support Systems, Inc.

Representatives

John L. Beard BUTZEL LONG

Technical classification

Nice Classes

Class 35Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Distributorship in the field of health care and medical equipment

Class 41

Educational servicestraining and training consultation with regard to the use of ambulatory infusion devices

Class 44

Providing health care and medical servicesdelivering chemotherapy drugnarcoticsregional anesthesia agents through ambulatory infusion devices; health care services in the nature of infusion therapy; consulting services concerning the use of ambulatory infusion devices

Publications

History of USPTO decisions and trademark events.

32 publications found

E815

TEAS SECTION 8 & 15 RECEIVED

05/29/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/09/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

02/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/02/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/01/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/31/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/30/2020

IUAF

USE AMENDMENT FILED

03/12/2020

EISU

TEAS STATEMENT OF USE RECEIVED

03/12/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/14/2019

EX1G

SOU EXTENSION 1 GRANTED

09/12/2019

EXT1

SOU EXTENSION 1 FILED

09/12/2019

EEXT

SOU TEAS EXTENSION RECEIVED

09/12/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/12/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/15/2019

PUBO

PUBLISHED FOR OPPOSITION

01/15/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/26/2018

ALIE

ASSIGNED TO LIE

12/06/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/17/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/15/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/15/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/15/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/11/2018

GNRT

NON-FINAL ACTION E-MAILED

10/11/2018

CNRT

NON-FINAL ACTION WRITTEN

10/11/2018

DOCK

ASSIGNED TO EXAMINER

10/09/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/26/2018

NWAP

NEW APPLICATION ENTERED

06/23/2018

Continuous trademark protection

Get notified about every new filing that threatens INFUDYNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.